mechanism of action of glp-1 receptor agonists as Treatments for Type 2 Diabetes What is GLP-1 and Its

Tirzepatide has been shown in clinical trials to reduce the risk of cardiovascular events at various doses, suggesting a potential treatment option for patients who are obese or overweight [2]

Higher doses could cost as much as $349 a month or $299 for those who refill within 45 days

Tirzepatide delivers stronger results but costs more

Because these drugs are temperature-sensitive biologics, traditional pill-in-a-bottle packaging is insufficient

Separate from body weight, the outcomes on markers of hepatic steatosis, fibrosis and inflammation will test the utilization of these compounds for nonalcoholic steatohepatitis (NASH)